Skip to content
The production of sustainable aviation fuel (SAF) should be encouraged to reduce the high carbon emissions from air travel, writes Biotechnology Innovation Organization (BIO) […]
‘Sustainable air travel is within reach’ – with biotech Read More »
Lifesaving science is under attack from potentially deadly misinformation, says the May 9 episode of the I am BIO Podcast, which features Food and
Misinformation is deadly, FDA Commissioner tells BIO’s podcast Read More »
On May 5, 2023, the World Health Organization (WHO) declared an end to the COVID-19 Public Health Emergency of International Concern (PHEIC), which began
WHO ends COVID-19 public health emergency—here’s what to know Read More »
A May 3 report shows that more than a quarter of a billion people faced acute food insecurity last year. This data underlines the
Nearly a quarter billion people are hungry. Can biotech help? Read More »
“What scientists are telling us is that there is a reasonable chance that—God forbid—a pandemic is deadly as COVID-19 could occur in 10 years,”
What they said at the Senate HELP hearing on PAHPA reauthorization Read More »
A current study suggests that scientists from Hiroshima University in Japan may have found a way to remove allergens that eggs usually contain. According
Egg allergens may be removed thanks to gene editing Read More »
Exciting new therapies promise to transform medicine. But ensuring patients can access these complex treatments may require innovative payment models, says a study published
Transformative therapies need new payment models, study finds Read More »
Drug makers have been racing at a breakneck pace to develop respiratory syncytial virus (RSV) vaccines this year. On May 3, the U.S. Food
FDA approves first RSV vaccine Read More »
The Senate Health, Education, Labor, and Pension (HELP) Committee on May 2 discussed Senate Bill 1339, “The Pharmacy Benefit Manager Reform Act,” and three
Vote on Pharmacy Benefit Manager Reform Act delayed until May 11 Read More »
On April 26, the U.S. Food and Drug Administration (FDA) approved the first investigational microbiome therapeutic for treating recurrent Clostridioides difficile infection in adults.
FDA approves first microbiome therapeutic for C. diff infection in adults Read More »
